Screener
Viridian Therapeutics, Inc. VRDN Shares (Diluted)
Shares (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Viridian Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.
The source filing: Viridian Therapeutics, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 7:31 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001590750-26-000018
| Line item | Three Months Ended June 30, 2025 / Series A Convertible Preferred Stock | Three Months Ended June 30, 2025 / Series B Convertible Preferred Stock | Three Months Ended June 30, 2025 / Common Stock | Six Months Ended June 30, 2025 / Series A Convertible Preferred Stock | Six Months Ended June 30, 2025 / Series B Convertible Preferred Stock | Six Months Ended June 30, 2025 / Common Stock |
|---|---|---|---|---|---|---|
| Numerator | ||||||
| Allocation of net loss | $(9,034) | $(9,723) | $(81,978) | $(16,848) | $(18,135) | $(152,664) |
| Denominator | ||||||
| Weighted-average shares outstanding | 134,864 | 145,160 | 81,593,463 | 134,864 | 145,160 | 81,471,496 |
| Net loss per share, basic and diluted | $(66.99) | $(66.98) | $(1.00) | $(124.93) | $(124.93) | $(1.87) |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Viridian Therapeutics, Inc.'s shares (diluted)?
- Viridian Therapeutics, Inc. (VRDN) reported shares (diluted) of 81.6M in Q2 2025.
- How has Viridian Therapeutics, Inc.'s shares (diluted) changed year-over-year?
- Viridian Therapeutics, Inc.'s shares (diluted) increased by 27.8% year-over-year, from 63.9M to 81.6M.
- What is the long-term trend for Viridian Therapeutics, Inc.'s shares (diluted)?
- Over 2 years (2021 to 2023), Viridian Therapeutics, Inc.'s shares (diluted) has grown at a 115.2% compound annual growth rate (CAGR), from 37.5M to 173.9M.
- What does shares (diluted) mean?
- The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.
Ask your AI about Viridian Therapeutics, Inc.'s shares (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude